Pharmacokinetic considerations in quinolone therapy

Area of Science:

• Pharmacology
• Microbiology

Background:

• Quinolones are effective antibiotics requiring careful administration.
• Understanding drug distribution and bioavailability is crucial for optimizing therapy.

Purpose of the Study:

• To provide guidance on optimizing quinolone therapy.
• To discuss strategies for sequential parenteral-to-oral conversion.
• To highlight key pharmacokinetic and drug interaction considerations.

Main Methods:

• Review of quinolone pharmacokinetics, including distribution and protein binding.
• Analysis of drug absorption, bioavailability, and elimination routes.
• Examination of potential drug-drug interactions and dosage adjustments.

Main Results:

• High volume of distribution and low protein binding indicate wide tissue penetration.
• Oral absorption of some quinolones (e.g., ofloxacin) is comparable to parenteral administration.
• Dosage adjustments are necessary for renal impairment and depend on the primary elimination route.
• Theophylline interactions are more significant with liver-metabolized quinolones.
• Optimal dosing involves maximizing tolerated doses due to concentration-dependent killing and postantibiotic effect.
• Antibacterial efficacy can be assessed using the Cmax:MIC90 ratio.

Conclusions:

• Sequential therapy with oral quinolones is effective and practical.
• Individualized dosing strategies are essential, considering patient-specific factors and drug properties.
• Careful management of drug interactions and elimination pathways ensures therapeutic success.